Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.972 USD | -2.80% | +0.01% | +78.57% |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Matthew Davis
COO | Chief Operating Officer | - | 22-06-30 |
Paul Spencer
IRC | Investor Relations Contact | - | 22-11-30 |
William Clementi
PRN | Corporate Officer/Principal | - | 23-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 194,612,289 | 63,738,859 ( 32.75 %) | 0 | 32.75 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ACCUSTEM SCIENCES, INC. 11.80% | 1,337,970 | 11.80% | 628,846 $ |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+78.57% | 102M | |
+51.85% | 57.87B | |
+41.11% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- TLSA Stock
- Company Tiziana Life Sciences Ltd